S&P 500   5,123.17 (-1.46%)
DOW   37,993.79 (-1.21%)
QQQ   438.63 (-1.51%)
AAPL   175.32 (+0.16%)
MSFT   422.42 (-1.29%)
META   514.35 (-1.68%)
GOOGL   158.15 (-0.79%)
AMZN   185.92 (-1.66%)
TSLA   171.61 (-1.71%)
NVDA   887.23 (-2.09%)
AMD   163.79 (-3.94%)
NIO   4.11 (-7.85%)
BABA   72.07 (-3.71%)
T   16.38 (-0.24%)
F   12.66 (-2.91%)
MU   123.48 (-3.16%)
GE   154.20 (-2.03%)
CGC   7.99 (-1.96%)
DIS   114.36 (-2.38%)
AMC   2.70 (-3.57%)
PFE   26.04 (-1.14%)
PYPL   64.87 (-1.41%)
XOM   121.64 (-0.12%)
S&P 500   5,123.17 (-1.46%)
DOW   37,993.79 (-1.21%)
QQQ   438.63 (-1.51%)
AAPL   175.32 (+0.16%)
MSFT   422.42 (-1.29%)
META   514.35 (-1.68%)
GOOGL   158.15 (-0.79%)
AMZN   185.92 (-1.66%)
TSLA   171.61 (-1.71%)
NVDA   887.23 (-2.09%)
AMD   163.79 (-3.94%)
NIO   4.11 (-7.85%)
BABA   72.07 (-3.71%)
T   16.38 (-0.24%)
F   12.66 (-2.91%)
MU   123.48 (-3.16%)
GE   154.20 (-2.03%)
CGC   7.99 (-1.96%)
DIS   114.36 (-2.38%)
AMC   2.70 (-3.57%)
PFE   26.04 (-1.14%)
PYPL   64.87 (-1.41%)
XOM   121.64 (-0.12%)
S&P 500   5,123.17 (-1.46%)
DOW   37,993.79 (-1.21%)
QQQ   438.63 (-1.51%)
AAPL   175.32 (+0.16%)
MSFT   422.42 (-1.29%)
META   514.35 (-1.68%)
GOOGL   158.15 (-0.79%)
AMZN   185.92 (-1.66%)
TSLA   171.61 (-1.71%)
NVDA   887.23 (-2.09%)
AMD   163.79 (-3.94%)
NIO   4.11 (-7.85%)
BABA   72.07 (-3.71%)
T   16.38 (-0.24%)
F   12.66 (-2.91%)
MU   123.48 (-3.16%)
GE   154.20 (-2.03%)
CGC   7.99 (-1.96%)
DIS   114.36 (-2.38%)
AMC   2.70 (-3.57%)
PFE   26.04 (-1.14%)
PYPL   64.87 (-1.41%)
XOM   121.64 (-0.12%)
S&P 500   5,123.17 (-1.46%)
DOW   37,993.79 (-1.21%)
QQQ   438.63 (-1.51%)
AAPL   175.32 (+0.16%)
MSFT   422.42 (-1.29%)
META   514.35 (-1.68%)
GOOGL   158.15 (-0.79%)
AMZN   185.92 (-1.66%)
TSLA   171.61 (-1.71%)
NVDA   887.23 (-2.09%)
AMD   163.79 (-3.94%)
NIO   4.11 (-7.85%)
BABA   72.07 (-3.71%)
T   16.38 (-0.24%)
F   12.66 (-2.91%)
MU   123.48 (-3.16%)
GE   154.20 (-2.03%)
CGC   7.99 (-1.96%)
DIS   114.36 (-2.38%)
AMC   2.70 (-3.57%)
PFE   26.04 (-1.14%)
PYPL   64.87 (-1.41%)
XOM   121.64 (-0.12%)

Eli Lilly and Company (LLY) SEC Filings & 10K Form

$755.30
-4.29 (-0.56%)
(As of 12:33 PM ET)

Recent Eli Lilly and Company SEC Filings

DateFilerForm TypeView
03/28/2024
12:10 PM
Chevedden John (Filed by)
Eli Lilly and Company (Subject)
Form PX14A6G
03/28/2024
11:20 AM
Eli Lilly and Company (Subject)
Trinity Health Corp (Filed by)
Form PX14A6G
03/11/2024
3:24 PM
Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
3:26 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:16 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
3:18 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2024
10:44 AM
Eli Lilly and Company (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/15/2024
2:05 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2024
3:43 PM
Dozier Eric (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:44 PM
Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:34 PM
Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:36 PM
Eli Lilly and Company (Issuer)
Skovronsky Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:23 PM
Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:25 PM
Eli Lilly and Company (Issuer)
Jonsson Patrik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
10:56 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/09/2024
8:26 AM
Eli Lilly and Company (Subject)
PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
Form SC 13G/A
02/08/2024
2:34 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/07/2024
4:08 PM
Eli Lilly and Company (Subject)
Form FWP
02/07/2024
7:12 AM
Eli Lilly and Company (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/06/2024
6:04 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:32 PM
Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Hakim Anat (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:20 PM
Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
2:26 PM
BlackRock Inc. (Filed by)
Eli Lilly and Company (Subject)
Form SC 13G/A
01/17/2024
3:15 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:17 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:19 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
2:22 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
3:05 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2024
1:15 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
2:11 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
5:40 PM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
12/18/2023
5:59 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
12/04/2023
3:17 PM
Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
6:04 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
11/21/2023
3:27 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:29 PM
Eli Lilly and Company (Issuer)
Runge Marschall S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:15 PM
Baicker Katherine (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:18 PM
Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:20 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:22 PM
Eli Lilly and Company (Issuer)
JACKSON JAMERE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:24 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
SHOCKING Altcoin Moves… (Ad)

Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…

Click here to register now
11/17/2023
5:53 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
11/15/2023
5:51 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
11/08/2023
4:06 PM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
11/06/2023
5:09 PM
Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
3:25 PM
Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2023
10:21 AM
Eli Lilly and Company (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
6:02 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/27/2023
3:15 PM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T/A
10/17/2023
3:19 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:21 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:22 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:24 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:15 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2023
3:18 PM
Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/13/2023
5:52 AM
Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
Form SC TO-T
10/12/2023
3:00 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2023
1:06 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
3:25 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:27 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:28 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:29 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:22 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:24 PM
Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2023
3:14 PM
Eli Lilly and Company (Issuer)
Weems Alonzo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2023
3:26 PM
Eli Lilly and Company (Subject)
Weems Alonzo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/07/2023
1:37 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2023
12:44 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2023
3:33 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:34 PM
Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:24 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:26 PM
Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:28 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:29 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2023
3:31 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2023
3:00 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
12:31 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/11/2023
2:50 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:34 AM
Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
Form SC TO-T/A
08/09/2023
1:32 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
8:14 AM
DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
Form SC TO-T/A
08/08/2023
12:23 PM
Eli Lilly and Company (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2023
6:01 AM
Eli Lilly and Company (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
3:46 PM
Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
Form SC TO-T/A
07/25/2023
6:04 AM
DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
Form SC TO-T/A
07/24/2023
2:55 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/21/2023
1:55 PM
Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/18/2023
3:33 PM
Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:36 PM
Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:40 PM
Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:43 PM
Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
SHOCKING Altcoin Moves… (Ad)

Bitcoin's recent price boom has sent select altcoins into an absolute FRENZY! Which is why we've gathered 27 crypto experts to share their top picks and predictions as we rapidly approach the Bitcoin halving event this month…

Click here to register now
07/18/2023
3:25 PM
Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:29 PM
Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:31 PM
Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
Form SC TO-T/A
07/17/2023
4:14 PM
DICE Therapeutics, Inc. (Subject)
Eli Lilly and Company (Filed by)
Form SC TO-T/A
07/13/2023
7:01 AM
Eli Lilly and Company (Filed by)
Sigilon Therapeutics, Inc. (Subject)
Form SC TO-T
07/07/2023
3:30 PM
Eli Lilly and Company (Reporting)
Shenandoah Acquisition Corp (Reporting)
Sigilon Therapeutics, Inc. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/03/2023
11:00 AM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
2:00 PM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
8:06 AM
Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:LLY) was last updated on 4/12/2024 by MarketBeat.com Staff

From Our Partners